Cargando…

Clinical management of psychosis in 22q11.2 deletion syndrome

Detalles Bibliográficos
Autores principales:	Iftimovici, Anton, Krebs, Marie-Odile, Chaumette, Boris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	CMA Impact Inc. 2022
Materias:	Psychopharmacology for the Clinician
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648635/ https://www.ncbi.nlm.nih.gov/pubmed/36347546 http://dx.doi.org/10.1503/jpn.220091

Ejemplares similares

Prescribing differently for women with first-episode psychosis
por: Sabesan, Priyadharshini, et al.
Publicado: (2021)

Utilizing pharmacogenetics when treating first episode psychosis
por: Korchia, Theo, et al.
Publicado: (2023)

The antipsychotic potential of cannabidiol: clinical implications for patients with psychosis and comorbid cannabis use disorder
por: Garel, Nicolas, et al.
Publicado: (2021)

Serotonin syndrome: SSRIs are not the only culprit
por: Garel, Nicolas, et al.
Publicado: (2021)

To continue or discontinue antidepressants in anxiety disorders? A dilemma for patients and clinicians
por: Muntingh, Anna, et al.
Publicado: (2021)

Elevated clozapine levels and toxic effects after SARS-CoV-2 vaccination
por: Thompson, Deborah, et al.
Publicado: (2021)

Binge eating disorder hidden behind a wall of anxiety disorders
por: Pipe, Amy, et al.
Publicado: (2021)

Use of MAOIs in severe treatment-resistant depression: back to the old school
por: Cookey, Jacob
Publicado: (2021)

Oculogyric crisis: a rare type of dystonia
por: Boi, Sara, et al.
Publicado: (2021)

Population pharmacokinetics and dosing of long-acting injectable antipsychotics
por: Kim, David D., et al.
Publicado: (2021)

Atypical antipsychotics, dystonia, and psychotic depression: old solutions for new problems
por: Gazzellone, Matthew J., et al.
Publicado: (2022)

Medical assistance in living after failure of ECT and ketamine
por: Lafrenière, Simon, et al.
Publicado: (2022)

Use of repetitive transcranial magnetic stimulation in the treatment of catatonia
por: Licht, Christiane, et al.
Publicado: (2022)

Metformin for the treatment of antipsychotic-induced metabolic disturbances in people with intellectual and developmental disabilities
por: Stogios, Nicolette, et al.
Publicado: (2023)

Mindfulness-based intervention for benzodiazepine deprescription in hemodialysis patients with anxiety and depressive symptoms
por: Garel, Nicolas, et al.
Publicado: (2023)

Favourable cognitive changes observed with metabolic improvements in a patient with severe mental illness
por: van Reekum, Emma A, et al.
Publicado: (2023)

A narrative review of the pharmacological management of psychosis in Alzheimer's disease
por: Matthews, Alexander, et al.
Publicado: (2021)

Shyness discriminates between children with 22q11.2 deletion syndrome and Williams syndrome and predicts emergence of psychosis in 22q11.2 deletion syndrome
por: Schonherz, Yael, et al.
Publicado: (2014)

22Q11.2 deletion syndrome and psychosis: About a case
por: García-Bernal, C., et al.
Publicado: (2021)

Multimorbidity and Polypharmacy in Psychosis: Identifying Potentially Significant Drug Interactions in an Old Age Inpatient Psychiatry Setting
por: Tewari, Abhinav, et al.
Publicado: (2023)

Case Report: Autoimmune Psychosis in Chromosome 22q11.2 Deletion Syndrome
por: Ciano-Petersen, Nicolás Lundahl, et al.
Publicado: (2021)

22q11.2 deletion syndrome and psychosis – regarding a clinical case
por: Santos Martins, F., et al.
Publicado: (2022)

Adult Height, 22q11.2 Deletion Extent, and Short Stature in 22q11.2 Deletion Syndrome
por: Heung, Tracy, et al.
Publicado: (2022)

Dysregulation of peripheral expression of the YWHA genes during conversion to psychosis
por: Demars, Fanny, et al.
Publicado: (2020)

An interictal schizophrenia-like psychosis in an adult patient with 22q11.2 deletion syndrome
por: Tastuzawa, Yasutaka, et al.
Publicado: (2015)

Emergent, remitted and persistent psychosis-spectrum symptoms in 22q11.2 deletion syndrome
por: Tang, S X, et al.
Publicado: (2017)

Subcortical Myoclonus and Associated Dystonia in 22q11.2 Deletion Syndrome
por: Van Iseghem, Vincent, et al.
Publicado: (2020)

Event-related potential (ERP) markers of 22q11.2 deletion syndrome and associated psychosis
por: Francisco, Ana A., et al.
Publicado: (2023)

Hematological abnormalities and 22q11.2 deletion syndrome
por: Rosa, Rafael Fabiano Machado, et al.
Publicado: (2011)

Obesity in adults with 22q11.2 deletion syndrome
por: Voll, S, et al.
Publicado: (2016)

Risk of malignancy in 22q11.2 deletion syndrome
por: Stevens, Toer, et al.
Publicado: (2017)

The Genetics and Epigenetics of 22q11.2 Deletion Syndrome
por: Du, Qiumei, et al.
Publicado: (2020)

Complement Activation in 22q11.2 Deletion Syndrome
por: Grinde, Dina, et al.
Publicado: (2020)

Laryngeal web with 22q11.2 deletion syndrome
por: Abe, Yasuhiro, et al.
Publicado: (2022)

Tonsillectomy in Children with 22q11.2 Deletion Syndrome
por: Arganbright, Jill M., et al.
Publicado: (2022)

Multicentre evaluation of the pharmacological management of women with bipolar disorder in the perinatal period
por: Dias, Marisa Casanova, et al.
Publicado: (2021)

A Mini Review on the Contribution of the Anterior Cingulate Cortex in the Risk of Psychosis in 22q11.2 Deletion Syndrome
por: Padula, Maria C., et al.
Publicado: (2018)

Stress, Cortisol and NR3C1 in At-Risk Individuals for Psychosis: A Mendelian Randomization Study
por: Iftimovici, Anton, et al.
Publicado: (2020)

Genotype-phenotype correlation in 22q11.2 deletion syndrome
por: Michaelovsky, Elena, et al.
Publicado: (2012)

Psychopathology and cognition in children with 22q11.2 deletion syndrome
por: Niarchou, Maria, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ld51ioquepo27grur5j5134ihr